Herantis Pharma Oyj (HEL: HRTIS)

Herantis Pharma Oyj Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	25	32	28	27	40	52
Market Cap Growth	16.40%	13.79%	4.72%	-34.19%	-21.79%	91.39%
Enterprise Value	21	31	25	26	39	53
Last Close Price	1.23	1.57	1.65	2.28	3.95	7.37
PE Ratio	-	96.78	-	-	-	-
Forward PE	-	-	-	-	1.42	-
PB Ratio	12.16	6.72	-462.92	-23.37	5.34	27.97
P/TBV Ratio	16.41	6.72	-	-	5.34	27.97
EV/EBIT Ratio	-	203.31	-	-	-	-
Debt / Equity Ratio	0.01	0.02	-75.33	-6.43	0.95	3.90
Quick Ratio	2.28	3.38	3.25	2.89	4.67	3.60
Current Ratio	2.30	3.39	3.28	2.91	4.68	3.61
Return on Equity (ROE)	-661.79%	11.99%	-	-396.06%	-193.95%	-908.72%
Return on Assets (ROA)	-2.75%	1.49%	-71.40%	-64.41%	-36.70%	-49.09%
Return on Capital (ROIC)	-5.09%	2.08%	-93.60%	-74.22%	-42.29%	-58.23%
Earnings Yield	-2.64%	0.88%	-33.41%	-47.91%	-22.60%	-15.46%
FCF Yield	-17.79%	-14.60%	-32.05%	-37.28%	-21.14%	-11.51%
Buyback Yield / Dilution	-10.24%	-17.34%	-43.59%	-38.03%	-26.51%	-18.83%
Total Shareholder Return	-10.24%	-17.34%	-43.59%	-38.03%	-26.51%	-18.83%

Source: S&P Capital IQ. Standard template. Financial Sources.